glp-1 obesity drug news today october 23 2025 The Multi-Sector Impacts of GLP-1RA Drugs GLP-1 Weight-Loss Drug Demonstration Begins

A research article about the doseresponse effects of survodutide, a dual agonist of the subcutaneous glucagon receptor and glucagon-like peptide- 1 receptor, on bodyweight loss and HbA1c levels

Research published in the journal Antioxidants indicates that oxidative stress and mitochondria are involved in anaphylaxis and mast cell degranulation

Intestinal microbiota affects thyroid function Trace elements have a prominent impact on the interaction between microbiota and thyroid and participate in the conversion and metabolism of thyroid hormones, thus affecting the function of the thyroid

Route of Elimination It is excreted primarily by the kidney, with about 50% excreted in one hour and over 95% within 24 hours.2 Almost none of the compound is metabolized